Decision Diagnostics Corp (DECN)

[rawman]

Every sentence in the post is a total misrepresentation of reality!

Per press release we are at clinical trials after going through the first phase of testing 95% accuracy ( feasibility) stage.

DECN has not even selected the organization to do the clinical trials and there was absolutely NO MENTION of 95% accuracy of anything in the PR!

The first stage done and after positive results the clinical trials are now warranted.

Please help all the readers! Please tell everybody all the about the so-called "first stage"!

What "positive results"?

Got any evidence of "positive results"?

Berman has NEVER mentioned a "first stage" and definitely NEVER detailed "positive results"!

For Berman 30% accuracy could be a "positive result" for Berman, but this is not good enough for the FDA or ANY medical practitioner!

Oh by the way vaccine unfortunately not till 2021 even if Pfizer got contract in press release its stated that hoping for early 2021 to get vaccines out for the 6 billion people. And still doing human trials but thankfully with great results but wont be quick enough for many, 8 months a long way away.

The above claim is complete and unadulterated nonsense! It is a total fabrication and does not come close to representing what was communicated by the CEO of Pfizer!

(JULY 13, 2020) -- Subject to regulatory approval, the companies are expecting to start a Phase 2b/3 trial as soon as later this month and are anticipating enrolling up to 30,000 subjects. If the ongoing studies are successful, and the vaccine candidate receives regulatory approval, the companies currently expect to manufacture up to 100 million doses by the end of 2020 and potentially more than 1.2 billion doses by the end of 2021.

And this is only Pfizer! The are now 20 vaccines, including the advanced candidate from Moderna, which are going through clinical trials. The U.S. Government is targeting to have 300,000,000 vaccine doses available by the end of this year!

From Science News:

Almost 200 vaccine candidates are in the works, with more than 20 in clinical trials around the world, according to a vaccine tracker maintained by the Milken Institute think tank. A vaccine candidate devised by the U.S. National Institute of Allergy and Infectious Diseases and the biotechnology company Moderna, based in Cambridge, Mass., also recently reported safety and antibody data. That mRNA vaccine candidate was the first to be tried in people.